IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Astec LifeSciences IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 61.50 Cr. The company is based in Mumbai and caters to Chemical - Speciality sector. Idbi Capital Market Services , Almondz Global Securities are the merchant bankers of Astec LifeSciences IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 8th August 2008.
Astec LifeSciences IPO posted revenues of ₹ 161.32 Cr. and PAT of ₹ 13.72 Cr. in FY10 on annualised basis.
Revenue:
₹ 161.32 Cr.
EBITDA Margin:
16.54
% 
Net Worth: ₹ 33.95 Cr.
Market Capitalisation:
[●]
P/E:
7.21 times
P/BV: [●]
EV/EBITDA: 1.42 times
Financial results of Astec LifeSciences IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Jun-09 | FY09 | FY08 | FY07 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 98.17 | 95.90 | 77.21 | 52.01 | |
| Net Worth | 33.95 | 30.51 | 21.37 | 14.42 | |
| Total Debt | 40.32 | 43.82 | 32.94 | 23.07 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
40.33
161.32 |
43.82 | 32.94 | 23.07 | |
EBITDA
EBITDA on annualised basis |
6.67
26.68 |
21.76 | 15.72 | 6.44 | |
PAT
PAT on annualised basis |
3.43
13.72 |
10.72 | 7.93 | 3.62 | |
Astec LifeSciences IPO PAT Margin is 8.50 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Astec LifeSciences IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Jun-09 | FY09 | FY08 | FY07 |
|---|---|---|---|---|
| EBITDA Margin (%) | 16.54 | 49.66 | 47.72 | 27.92 |
| PAT Margin (%) | 8.50 | 24.46 | 24.07 | 15.69 |
| EPS (₹) | 3.64 | 11.38 | 8.42 | [●] |
| ROE (%) | 10.10 | 35.14 | 37.11 | 25.10 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 3.49 | 11.18 | 10.27 | 6.96 |
| Debt to Equity | 1.19 | 1.44 | 1.54 | 1.60 |
The market Capitalisation of Astec LifeSciences IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Astec LifeSciences IPO prospectus highlights an Return on Equity (ROE) of 10.10 % , Return on Assets (ROA) of 3.49 %, and an EBITDA Margin of 16.54 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Astec LifeSciences IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Astec LifeSciences IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Astec LifeSciences IPO has a Price-to-Earnings (PE) ratio of 7.21 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Astec LifeSciences IPO reported revenue of ₹ 93.72 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Astec LifeSciences IPO provide insights into sales growth, market demand, and business scalability.
Astec LifeSciences recorded an EBITDA of ₹ 26.68 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Astec LifeSciences Profit After Tax (PAT) is ₹ 13.72 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 161.32 Cr.
EBITDA Margin:
16.54
%
Net Worth: ₹ 33.95 Cr.
Market Capitalisation:
[●]
P/E:
7.21 times
P/BV: [●]
EV/EBITDA:
[●]
Astec LifeSciences operates in Chemical - Speciality and Business Of Agrochemicals And Pharmaceuticals. The Issue is listed on BSE,NSE in Nov, 2009. Astec LifeSciences IPO size was 61.50 with Issue price of 82.00 .
Merchant Banker(s) of Astec LifeSciences IPO: Idbi Capital Market Services Limited , Almondz Global Securities Limited
Astec LifeSciences IPO subscription was 1.56 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Astec LifeSciences IPO listed at a listing price of 83.90 against the offer price of 82.00.
The current market price of Astec LifeSciences is 783.35.
Why Us?
